Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Sandner

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Sexual Medicine|November 27, 2019
Testosterone Induces Relaxation of Human Corpus Cavernosum Tissue of Patients With Erectile DysfunctionThomas Van den Broeck, Mohammad Ayodhia Soebadi, Annelies Falter, et al.
Annals of the Rheumatic Diseases|February 26, 2014
Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGFβ signallingChristian Beyer, Christoph Zenzmaier, Katrin Palumbo-Zerr, et al.
International Journal of Molecular Sciences|September 9, 2023
The sGC Activator Runcaciguat Has Kidney Protective Effects and Prevents a Decline of Kidney Function in ZSF1 RatsJan R Kraehling, Agnes Benardeau, Tibor Schomber, et al.
The Journal of Pathology|December 22, 2021
Benign prostatic hyperplasia/obstruction ameliorated using a soluble guanylate cyclase activatorIrina V Zabbarova, Youko Ikeda, Mark G Kozlowski, et al.
Frontiers in Physiology|June 12, 2020
Enhanced Cardiomyocyte Function in Hypertensive Rats With Diastolic Dysfunction and Human Heart Failure Patients After Acute Treatment With Soluble Guanylyl Cyclase (sGC) ActivatorDetmar Kolijn, Árpád Kovács, Melissa Herwig, et al.
ESC Heart Failure|September 18, 2020
Mineralocorticoid receptor antagonism by finerenone is sufficient to improve function in preclinical muscular dystrophyJeovanna Lowe, Peter Kolkhof, Michael J Haupt, et al.
Nature Cardiovascular Research|July 24, 2023
Loss of soluble guanylyl cyclase in platelets contributes to atherosclerotic plaque formation and vascular inflammationCarina Mauersberger, Hendrik B Sager, Jana Wobst, et al.
Respiratory Research|October 1, 2022
Inhaled mosliciguat (BAY 1237592): targeting pulmonary vasculature via activating apo-sGCEva M Becker-Pelster, Michael G Hahn, Martina Delbeck, et al.
JCI Insight|February 23, 2018
Nitric oxide-sensitive guanylyl cyclase stimulation improves experimental heart failure with preserved ejection fractionNicola Wilck, Lajos Markó, András Balogh, et al.
Aging Cell|August 27, 2022
Soluble guanylate cyclase activator BAY 54-6544 improves vasomotor function and survival in an accelerated ageing mouse modelEhsan Ataei Ataabadi, Keivan Golshiri, Annika A Jüttner, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Sexual Medicine|November 27, 2019
Testosterone Induces Relaxation of Human Corpus Cavernosum Tissue of Patients With Erectile DysfunctionThomas Van den Broeck, Mohammad Ayodhia Soebadi, Annelies Falter, et al.
Annals of the Rheumatic Diseases|February 26, 2014
Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGFβ signallingChristian Beyer, Christoph Zenzmaier, Katrin Palumbo-Zerr, et al.
International Journal of Molecular Sciences|September 9, 2023
The sGC Activator Runcaciguat Has Kidney Protective Effects and Prevents a Decline of Kidney Function in ZSF1 RatsJan R Kraehling, Agnes Benardeau, Tibor Schomber, et al.
The Journal of Pathology|December 22, 2021
Benign prostatic hyperplasia/obstruction ameliorated using a soluble guanylate cyclase activatorIrina V Zabbarova, Youko Ikeda, Mark G Kozlowski, et al.
Frontiers in Physiology|June 12, 2020
Enhanced Cardiomyocyte Function in Hypertensive Rats With Diastolic Dysfunction and Human Heart Failure Patients After Acute Treatment With Soluble Guanylyl Cyclase (sGC) ActivatorDetmar Kolijn, Árpád Kovács, Melissa Herwig, et al.
ESC Heart Failure|September 18, 2020
Mineralocorticoid receptor antagonism by finerenone is sufficient to improve function in preclinical muscular dystrophyJeovanna Lowe, Peter Kolkhof, Michael J Haupt, et al.
Nature Cardiovascular Research|July 24, 2023
Loss of soluble guanylyl cyclase in platelets contributes to atherosclerotic plaque formation and vascular inflammationCarina Mauersberger, Hendrik B Sager, Jana Wobst, et al.
Respiratory Research|October 1, 2022
Inhaled mosliciguat (BAY 1237592): targeting pulmonary vasculature via activating apo-sGCEva M Becker-Pelster, Michael G Hahn, Martina Delbeck, et al.
JCI Insight|February 23, 2018
Nitric oxide-sensitive guanylyl cyclase stimulation improves experimental heart failure with preserved ejection fractionNicola Wilck, Lajos Markó, András Balogh, et al.
Aging Cell|August 27, 2022
Soluble guanylate cyclase activator BAY 54-6544 improves vasomotor function and survival in an accelerated ageing mouse modelEhsan Ataei Ataabadi, Keivan Golshiri, Annika A Jüttner, et al.
Pageof 11